The NLRP3 inflammasome modulates tau pathology and neurodegeneration in a tauopathy model

Feb 17, 2022Glia

The NLRP3 inflammasome may influence tau protein buildup and brain cell loss in a tau-related disease model

AI simplified

Abstract

NLRP3 deficiency led to a significant decrease in tau pathology and hippocampal atrophy in a mouse model of tauopathies.

  • Tau pathology in the hippocampus and cortex was significantly lower in NLRP3-deficient mice compared to those with normal NLRP3.
  • NLRP3 deficiency was associated with reduced hippocampal atrophy, suggesting a role of NLRP3 in neurodegeneration.
  • The absence of NLRP3 significantly decreased the prion-like seeding and propagation of tau pathology.
  • Decreased tau pathology was observed in the hippocampus and cortex following tau seeding in NLRP3-deficient mice.
  • Hippocampal atrophy at 8 months was significantly less in tau-seeded NLRP3-deficient mice.

AI simplified

Key numbers

significantly decreased
Decrease in Tau Pathology
Tau pathology in hippocampus and cortex in NLRP3 deficient mice.
significantly decreased
Decrease in Hippocampal Atrophy
Hippocampal atrophy in tau.NLRP3−/− vs. tau.NLRP3+/+ mice.
significantly decreased
Decrease in Tau Propagation
Prion-like propagation of tau pathology in NLRP3 deficient mice.

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free